title: Would Fred Sanger get funded today?
abstract: Fred Sanger developed technologies that won him two Nobel Prizes and revolutionized biological research. Yet, in spite of this record, the question has been raised as to whether, in the current scientific climate, he might be unsuccessful in obtaining a grant because of a productivity that would be viewed as too limited. In imagining how a National Institutes of Health study section today might treat a proposal from Sanger to sequence DNA, we can ask whether there are lessons from his career that suggest changes to the grant review process.
authors.affiliation: Howard Hughes Medical Institute, Department of Genome Sciences and Department of Medicine, University of Washington, Seattle, Washington 98195 fields@uw.edu.
authors.forename: Stanley
authors.initials: S
authors.lastname: Fields
mesh_terms: D005380:Financing, Government; D009316:National Institutes of Health (U.S.); D011643:Publishing; D012109:Research Support as Topic; D014481:United States